Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial

  • Young Suk Lim
  • , Ming Lung Yu
  • , Jonggi Choi
  • , Chi Yi Chen
  • , Won Mook Choi
  • , Wonseok Kang
  • , Gi Ae Kim
  • , Hyung Joon Kim
  • , Yun Bin Lee
  • , Jeong Hoon Lee
  • , Neung Hwa Park
  • , So Young Kwon
  • , Soo Young Park
  • , Ji Hoon Kim
  • , Gwang Hyeon Choi
  • , Eun Sun Jang
  • , Chien Hung Chen
  • , Yao Chun Hsu
  • , Ming Jong Bair
  • , Pin Nan Cheng
  • Hung Da Tung, Te Sheng Chang, Ching Chu Lo, Kuo chih Tseng, Sheng Shun Yang, Cheng Yuan Peng, Seungbong Han

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science